Joe Muldoon | Source | CEO at FAST BioMedical

Joe Muldoon

CEO at FAST BioMedical
On the record
Share profile 
Recent Quotes
Sign up to view all

  • Welcoming Jim to our Board is a pleasure. His unique breadth of expertise in advancing technologies in heart failure and cardiorenal combined with his track record of capitalizing and positioning them to be the standard of care, through successful exit, fits perfectly with our strategy.

Media
Sign up to view all
  • Jim Dillon, Former St. Jude Medical Executive, Joins FAST BioMedical Board of Directors

    INDIANAPOLIS (Nov. 2, 2020) — FAST BioMedical, a privately held late clinical-stage medical technology company, today announces it has named Jim Dillon to its Board of Directors. Dillon is a former St. Jude Medical and Abiomed executive, with significant experience capitalizing and commercializing first-in-class heart failure and cardiorenal syndrome technologies.

    Article
Employment
Sign up to view all